{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:23:25Z","timestamp":1786123405294,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"name":"Guangdong Provincial Hospital Pharmacy Research Foundation","award":["2016MZ13"],"award-info":[{"award-number":["2016MZ13"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>While ropivacaine\u2013dexmedetomidine coadministration is widely used in surgical anesthesia, its pharmacokinetic effects in lumbar plexus blocks (LPB) remain uncharacterized. We therefore conducted a prospective randomized trial to evaluate dexmedetomidine\u2019s modulation of ropivacaine\u2019s pharmacokinetics and pharmacodynamics during unilateral lower limb surgery. Additionally, this study seeks to establish a dosing regimen for ropivacaine in combination with dexmedetomidine for LPB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Patients undergoing unilateral lower limb surgery were randomly allocated to 1 of 3 groups using a random-number table. The study included a control group receiving only ropivacaine, and 2 experimental groups receiving ropivacaine combined with either 0.25 or 0.5 \u00b5g\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      of dexmedetomidine, all administered perineurally. Clinical efficacy data were gathered and analyzed using statistical software to assess the pharmacodynamics of the three treatment regimens. Furthermore, data from all patients were used to develop a population pharmacokinetics model for ropivacaine, and pharmacokinetic parameters were determined. Using Bayesian estimation, we simulated ropivacaine dosing across body weights of 56 to 76 kg to identify doses where plasma concentrations exceed the toxicity threshold (4.3 \u00b1 0.6 \u00b5g\u00b7mL\n                      <jats:sup>\u22121<\/jats:sup>\n                      , mean \u00b1 standard deviation).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 46 patients were enrolled in the study. Ropivacaine pharmacokinetics were best described by a 2-compartment model, with body weight and dexmedetomidine coadministration as significant covariates. Simulations indicated that for LPB, the modeled toxic dose decreased from 4.9 to 3.0 mg\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      (with 0.5 \u00b5g\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      dexmedetomidine) and from 3.3 to 2.1 mg\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      (without dexmedetomidine) as body weight increased from 56 to 76 kg. The inclusion of 0.5 \u00b5g\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      dexmedetomidine significantly reduced the maximum concentration of ropivacaine (mean difference, 0.8 \u00b5g\u00b7mL\n                      <jats:sup>\u22121<\/jats:sup>\n                      ; 95% confidence interval [CI], 0.5\u20131.2 \u00b5g\u00b7mL\n                      <jats:sup>\u22121<\/jats:sup>\n                      ;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001), increased the apparent volume of distribution (33.1 L; 95% CI, 13.4\u201352.8 L;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .013), prolonged the time to maximum concentration (5 minutes; 95% CI, 1\u20139;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .011), and reduced the onset time of sensory blockade (5 minutes; 95% CI, 2\u20136;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001), while also extending the duration of sensory blockade (175 minutes; 95% CI, 55\u2013294;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .005). The addition of 0.25 \u00b5g\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      dexmedetomidine to ropivacaine did not change outcomes compared to ropivacaine alone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>\n                      Our research demonstrated that dexmedetomidine significantly influences the pharmacokinetics and pharmacodynamics of ropivacaine in LPB. When combining dexmedetomidine 0.5 \u00b5g\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      with ropivacaine for LPB in a 66 kg adult, the maximum ropivacaine dose should not exceed 3.7 mg\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000007871","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T15:00:18Z","timestamp":1764860418000},"page":"355-363","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Influence of Dexmedetomidine Added to Ropivacaine on Its Pharmacokinetic and Pharmacodynamic Effects During Lumbar Plexus Block"],"prefix":"10.1213","volume":"143","author":[{"given":"Zeyuan","family":"He","sequence":"first","affiliation":[{"name":"Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Huang","sequence":"additional","affiliation":[{"name":"Anesthesiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Chen","sequence":"additional","affiliation":[{"name":"Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[{"name":"Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ye","sequence":"additional","affiliation":[{"name":"Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiebin","family":"Ou","sequence":"additional","affiliation":[{"name":"Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Wu","sequence":"additional","affiliation":[{"name":"Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Yu","sequence":"additional","affiliation":[{"name":"Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"suppl 1","key":"R1-20260702","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2044.2010.06240.x","article-title":"Lower limb blocks.","volume":"65","author":"Murray","year":"2010","journal-title":"Anaesthesia"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/bja\/78.5.507","article-title":"Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers.","volume":"78","author":"Knudsen","year":"1997","journal-title":"Br J Anaesth"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1213\/ANE.0b013e31826c8095","article-title":"Myocardial accumulation of bupivacaine and ropivacaine is associated with reversible effects on mitochondria and reduced myocardial function.","volume":"116","author":"Hiller","year":"2013","journal-title":"Anesth Analg"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2147\/DDDT.S405294","article-title":"Dexmedetomidine as an adjuvant in peripheral nerve block.","volume":"17","author":"Chen","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1097\/00000539-200211000-00055","article-title":"The effect of the addition of epinephrine on early systemic absorption of epidural ropivacaine in humans.","volume":"95","author":"Lee","year":"2002","journal-title":"Anesth Analg"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF03018647","article-title":"In children, the addition of epinephrine modifies the pharmacokinetics of ropivacaine injected caudally.","volume":"50","author":"Van Obbergh","year":"2003","journal-title":"Can J Anaesth"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/00000542-200510000-00008","article-title":"Arterial and venous pharmacokinetics of ropivacaine with and without epinephrine after thoracic paravertebral block.","volume":"103","author":"Karmakar","year":"2005","journal-title":"Anesthesiology"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/bja\/aew411","article-title":"Evidence basis for using perineural dexmedetomidine to enhance the quality of brachial plexus nerve blocks: a systematic review and meta-analysis of randomized controlled trials.","volume":"118","author":"Vorobeichik","year":"2017","journal-title":"Br J Anaesth"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/AAP.0000000000000564","article-title":"Investigating the efficacy of dexmedetomidine as an adjuvant to local anesthesia in brachial plexus block: a systematic review and meta-analysis of 18 randomized controlled trials.","volume":"42","author":"Hussain","year":"2017","journal-title":"Reg Anesth Pain Med"},{"key":"R10-20260702","first-page":"711","article-title":"Impact of local administration of various doses of dexmedetomidine on ropivacaine-induced lumbar plexus-sciatic nerve block.","volume":"16","author":"Yu","year":"2018","journal-title":"Exp Ther Med"},{"key":"R11-20260702","first-page":"1207","article-title":"The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine.","volume":"91","author":"Jokinen","year":"2000","journal-title":"Anesth Analg"},{"key":"R12-20260702","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00000542-199501000-00026","article-title":"Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450.","volume":"82","author":"Oda","year":"1995","journal-title":"Anesthesiology"},{"key":"R13-20260702","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0009-9236(98)90131-X","article-title":"Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors.","volume":"64","author":"Arlander","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"R14-20260702","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1742-7843.2009.00533.x","article-title":"Optimal design of pharmacokinetic studies.","volume":"106","author":"Aarons","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R15-20260702","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10928-005-0078-3","article-title":"Sample size computations for PK\/PD population models.","volume":"32","author":"Kang","year":"2005","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R16-20260702","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40262-017-0617-2","article-title":"Population pharmacokinetic-pharmacodynamic modeling of ropivacaine in spinal anesthesia.","volume":"57","author":"Djerada","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"R17-20260702","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00228-012-1311-9","article-title":"Population pharmacokinetics of lamotrigine in Indian epileptic patients.","volume":"69","author":"Mallaysamy","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"R18-20260702","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2125.2012.04470.x","article-title":"Pharmacokinetics of 450 mg ropivacaine with and without epinephrine for combined femoral and sciatic nerve block in lower extremity surgery. A pilot study.","volume":"75","author":"Schoenmakers","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"R19-20260702","first-page":"614","article-title":"Analgesic efficacy and early functional outcome of continuous psoas plexus and sciatic nerve block in total knee arthroplasty %.","volume":"18","author":"Liao","year":"2012","journal-title":"J Chin J Pain Med"},{"key":"R20-20260702","doi-asserted-by":"crossref","first-page":"bbab138","DOI":"10.1093\/bib\/bbab138","article-title":"Pharmacometabonomics: data processing and statistical analysis.","volume":"22","author":"Fu","year":"2021","journal-title":"Brief Bioinform"},{"key":"R21-20260702","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00228-024-03800-8","article-title":"Association of obesity with ropivacaine and sufentanil EC50 in labor analgesia: a single-center prospective study.","volume":"81","author":"Liu","year":"2025","journal-title":"Eur J Clin Pharmacol"},{"key":"R22-20260702","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/17512433.2021.1929924","article-title":"Obesity decreases the EC50 of epidural ropivacaine when combined with dexmedetomidine for labor analgesia.","volume":"14","author":"Chen","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R23-20260702","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/bcpt.12008","article-title":"The effects of lidocaine used in sciatic nerve on the pharmacodynamics and pharmacokinetics of ropivacaine in sciatic nerve combined with lumbar plexus blockade: a double-blind, randomized study.","volume":"112","author":"Chen","year":"2013","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R24-20260702","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00540-014-1864-0","article-title":"Plasma ropivacaine concentration following ultrasound-guided subcostal transversus abdominis plane block in adults.","volume":"29","author":"Toju","year":"2015","journal-title":"J Anesth"},{"key":"R25-20260702","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1213\/ANE.0b013e3182367a68","article-title":"Brief reports: plasma ropivacaine concentrations after ultrasound-guided rectus sheath block in patients undergoing lower abdominal surgery.","volume":"114","author":"Wada","year":"2012","journal-title":"Anesth Analg"},{"key":"R26-20260702","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1365-2044.2007.05197.x","article-title":"The pharmacokinetics of ropivacaine after four different techniques of brachial plexus blockade.","volume":"62","author":"Rettig","year":"2007","journal-title":"Anaesthesia"},{"key":"R27-20260702","doi-asserted-by":"crossref","first-page":"18","DOI":"10.23736\/S0375-9393.17.11538-5","article-title":"Efficacy of US-guided transversus abdominis plane block and rectus sheath block with ropivacaine and dexmedetomidine in elderly high-risk patients.","volume":"84","author":"Xu","year":"2018","journal-title":"Minerva Anestesiol"},{"key":"R28-20260702","doi-asserted-by":"crossref","first-page":"1099699","DOI":"10.3389\/fped.2023.1099699","article-title":"Analgesic effect of ropivacaine combined with dexmedetomidine in the postoperative period in children undergoing ultrasound-guided single-shot sacral epidural block: a systematic review and meta-analysis.","volume":"11","author":"Quan","year":"2023","journal-title":"Front Pediatr"},{"key":"R29-20260702","doi-asserted-by":"crossref","first-page":"612216","DOI":"10.3389\/fphar.2021.612216","article-title":"Effects of three different doses of dexmedetomidine and ropivacaine on analgesia and the stress response in hypospadias surgery: a randomized trial.","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol"},{"key":"R30-20260702","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/bja\/aer154","article-title":"Population pharmacokinetic analysis of ropivacaine and its metabolite 2\u2019,6\u2019-pipecoloxylidide from pooled data in neonates, infants, and children.","volume":"107","author":"Aarons","year":"2011","journal-title":"Br J Anaesth"},{"key":"R31-20260702","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bja.2020.11.038","article-title":"Population pharmacokinetics of ropivacaine used for local infiltration anaesthesia during primary total unilateral and simultaneous bilateral knee arthroplasty.","volume":"126","author":"Gromov","year":"2021","journal-title":"Br J Anaesth"},{"key":"R32-20260702","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000542-200104000-00009","article-title":"Caudal ropivacaine in infants: population pharmacokinetics and plasma concentrations.","volume":"94","author":"Hansen","year":"2001","journal-title":"Anesthesiology"},{"key":"R33-20260702","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/joacp.joacp_353_22","article-title":"Ropivacaine pharmacokinetics in the arterial and venous pools after ultrasound-guided continuous thoracic paravertebral nerve block.","volume":"40","author":"Matsota","year":"2024","journal-title":"J Anaesth Clin Pharmacol"},{"key":"R34-20260702","first-page":"564","article-title":"Maximum recommended doses of local anesthetics: a multifactorial concept.","volume":"29","author":"Rosenberg","year":"2004","journal-title":"Reg Anesth Pain Med"},{"key":"R35-20260702","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/EJA.0000000000000265","article-title":"The Shamrock lumbar plexus block: a dose-finding study.","volume":"32","author":"Sauter","year":"2015","journal-title":"Eur J Anaesthesiol"},{"key":"R36-20260702","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/11538690-000000000-00000","article-title":"Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.","volume":"50","author":"Han","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"R37-20260702","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/anae.15288","article-title":"Perineural and intravenous dexamethasone and dexmedetomidine: network meta-analysis of adjunctive effects on supraclavicular brachial plexus block.","volume":"76","author":"Sehmbi","year":"2021","journal-title":"Anaesthesia"},{"key":"R38-20260702","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1186\/s13018-023-04333-z","article-title":"Periarticular infiltration used in total joint replacements: an update and review article.","volume":"18","author":"King","year":"2023","journal-title":"J Orthop Surg Res"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:55Z","timestamp":1786112815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000007871","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}